|
|
Studies of Normal and Neoplastic Prostate
|
5U01CA015062-32
|
$215,048
|
AHMED, KHALIL
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
|
|
Participation in the Eastern Cooperative Oncology Group
|
5U10CA107868-04
|
$234,166
|
AISNER, JOSEPH
|
UNIV OF MED/DENT NJ-R W JOHNSON MED SCH
|
|
|
Arizona Cancer Center Support Grant
|
3P30CA023074-30S1
|
$363,313
|
ALBERTS, DAVID
|
UNIVERSITY OF ARIZONA
|
|
|
Arizona Cancer Center Support Grant
|
3P30CA023074-30S2
|
$113,227
|
ALBERTS, DAVID
|
UNIVERSITY OF ARIZONA
|
|
|
Arizona Cancer Center Support Grant
|
3P30CA023074-30S3
|
$327,884
|
ALBERTS, DAVID
|
UNIVERSITY OF ARIZONA
|
|
|
Arizona Cancer Center Support Grant
|
3P30CA023074-30S4
|
$88,172
|
ALBERTS, DAVID
|
UNIVERSITY OF ARIZONA
|
|
|
Arizona Cancer Center Support Grant
|
5P30CA023074-30
|
$4,124,404
|
ALBERTS, DAVID
|
UNIVERSITY OF ARIZONA
|
|
|
NANOTHERAPEUTIC STRATEGY FOR MULTIDRUG RESISTANT TUMORS
|
5R01CA119617-03
|
$359,916
|
AMIJI, MANSOOR
|
NORTHEASTERN UNIVERSITY
|
|
|
Santa Rosa Memorial Hospital Regional CCOP
|
3U10CA063850-12S2
|
$131,400
|
ANDERSON, IAN
|
SANTA ROSA MEMORIAL HOSPITAL
|
|
|
SPORE in Breast Cancer
|
5P50CA098131-05
|
$2,360,642
|
ARTEAGA, CARLOS
|
VANDERBILT UNIVERSITY
|
|
|
Eastern Cooperative Oncology Group
|
2U10CA080775-09
|
$128,678
|
ATKINS, MICHAEL
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
|
Southeast Cancer Control Consortium, Inc
|
3U10CA045808-21S1
|
$170,000
|
ATKINS, JAMES
|
SOUTHEAST CANCER CONTROL CONSORTIUM
|
|
|
Southeast Cancer Control Consortium, Inc
|
5U10CA045808-21
|
$1,860,642
|
ATKINS, JAMES
|
SOUTHEAST CANCER CONTROL CONSORTIUM
|
|
|
Telomeres, telomerase and chemotherapy: Bench to bedside
|
2R01CA077091-04A2
|
$312,217
|
Au, Jessie
|
OHIO STATE UNIVERSITY
|
|
|
Eastern Cooperative Oncology Group Studies
|
5U10CA014548-33
|
$413,938
|
AVERBOOK, BRUCE
|
CASE WESTERN RESERVE UNIVERSITY
|
|
|
SAN JUAN MB COMMUNITY CLINICAL ONCOLOGY PROGRAM
|
5U10CA052667-17
|
$484,826
|
BAEZ, LUIS
|
SAN JUAN CITY HOSPITAL
|
|
|
Vitamin D and Ovarian Cancer Prevention and Treatment
|
5R01CA111334-03
|
$244,382
|
BAI, WENLONG
|
UNIVERSITY OF SOUTH FLORIDA
|
|
|
Southwest Oncology Group
|
2U10CA027057-28
|
$255,214
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
|
Southwest Oncology Group
|
3U10CA027057-28S1
|
$43,000
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
|
Interim SWOG Committee Renewals (Breast, Head & Neck, Leukemia)
|
3U10CA032102-28S1
|
$187,055
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
|
SOUTHWEST ONCOLOGY GROUP - OPERATIONS OFFICE
|
3U10CA032102-28S2
|
$159,600
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
|
SOUTHWEST ONCOLOGY GROUP - OPERATIONS OFFICE
|
3U10CA032102-28S3
|
$316,222
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
|
DNA-linked dendrimer nanoparticle systems for diagnosis
|
5R01CA119409-03
|
$471,871
|
Baker, James
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
|
SOUTHWEST ONCOLOGY GROUP - OPERATIONS OFFICE
|
5U10CA032102-28
|
$9,423,958
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
|
WUMC-Cancer and Leukemia Group B
|
5U10CA077440-10
|
$334,381
|
BARTLETT, NANCY
|
WASHINGTON UNIVERSITY
|
|
|
University of Texas MD Anderson SPORE in Ovarian Cancer
|
5P50CA083639-08
|
$2,249,522
|
BAST, ROBERT
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
|
Clinical Studies of Multidrug Resistance Reversal
|
Z01 BC 010620
|
$176,464
|
Bates, Susan
|
CCR (NCI)
|
|
|
UPSTATE CAROLINA COMMUNITY CLINICAL ONCOLOGY PROGRAM
|
2U10CA035119-23
|
$1,740,827
|
BEARDEN, JAMES
|
SPARTANBURG REGIONAL MEDICAL CENTER
|
|
|
Eastern Cooperative Oncology Group Clinical Trials
|
5U10CA017145-32
|
$456,370
|
BENSON, AL
|
NORTHWESTERN UNIVERSITY
|
|
|
RRM1/PTEN Axis in Non-Small Cell Lung Cancer
|
5R01CA102726-05
|
$461,937
|
BEPLER, GEROLD
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
|
Geisinger Clinical Oncology Program
|
5U10CA035448-24
|
$458,852
|
BERNATH, ALBERT
|
GEISINGER MEDICAL CENTER
|
|
|
Gynecologic Oncology Group Statistical and Data Center
|
5U10CA037517-23
|
$4,654,021
|
BLESSING, JOHN
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
|
Cancer and Leukemia Group B - The Ohio State University
|
5U10CA077658-10
|
$434,962
|
BLOOMFIELD, CLARA
|
OHIO STATE UNIVERSITY
|
|
|
Treatment of Malignant Gliomas with 2-5A-anti-hTR
|
5R01CA108558-04
|
$293,510
|
BOGLER, OLIVER
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
|
Fullerene Immunoconjugates for Cancer Imaging and Treatment
|
1R43CA128277-01
|
$200,937
|
BOLSKAR, ROBERT
|
TDA RESEARCH, INC.
|
|
|
Viral Vectors in Tumors: Effects of Taxol and Radiation
|
5R01CA098706-05
|
$268,835
|
BOUCHER, YVES
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
|
Metal Chelate Conjugated Monoclonal Antibodies for Tumor Diagnosis and Therapy
|
Z01 SC 006353
|
$459,276
|
Brechbiel, Martin
|
CCR (NCI)
|
|
|
University of Michigan Comprehensive Cancer Center CCOP*
|
3U10CA074648-06S1
|
$14,723
|
Brenner, Dean
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
|
North Central Cancer Treatment Group
|
2U10CA025224-28
|
$6,270,833
|
BUCKNER, JAN
|
MAYO CLINIC COLL OF MEDICINE, ROCHESTER
|
|
|
North Central Cancer Treatment Group
|
3U10CA025224-28S1
|
$222,000
|
BUCKNER, JAN
|
MAYO CLINIC COLL OF MEDICINE, ROCHESTER
|
|
|
North Central Cancer Treatment Group
|
3U10CA025224-28S2
|
$300,000
|
BUCKNER, JAN
|
MAYO CLINIC COLL OF MEDICINE, ROCHESTER
|
|
|
North Central Cancer Treatment Group
|
3U10CA025224-28S3
|
$2,543,699
|
BUCKNER, JAN
|
MAYO CLINIC COLL OF MEDICINE, ROCHESTER
|
|
|
Southwest Oncology Group
|
2U10CA004919-48
|
$192,303
|
BUDD, G
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
|
|
Southwest Oncology Group
|
3U10CA004919-48S1
|
$25,000
|
BUDD, G
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
|
|
Thermally Targeted Delivery of DOX
|
1R43CA126318-01A1
|
$179,980
|
BUDDE, RAYMOND
|
HOUSTON PHARMACEUTICALS, INC.
|
|
|
Cell Survival and Cancer
|
5P01CA078890-08
|
$1,371,447
|
CALABRETTA, BRUNO
|
THOMAS JEFFERSON UNIVERSITY
|
|
|
The Ohio State University Comprehensive Cancer Center-Supplement
|
3P30CA016058-32S1
|
$232,765
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
|
The Ohio State University Comprehensive Cancer Center
|
3P30CA016058-32S2
|
$84,897
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
|
The Ohio State University Comprehensive Cancer Center
|
5P30CA016058-32
|
$3,716,537
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
|
Cancer and Leukemia Group B-Leukemia Correlative Science
|
5U10CA101140-05
|
$994,868
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|
